This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Source: OpenUrlAbstract/FREE Full Text
Investigators from multiple institutions in France conducted a retrospective cohort study to assess the risk of oral propranolol for treatment of children with infantile hemangioma (IH). Data for this study were obtained from a national medico-administrative database that is linked to a hospital discharge database and covers 98.8% of the French population. This database contains demographic data; medical and drug reimbursements; laboratory test results; outpatient medical care consultations; and hospitalizations with primary, related, and associated diagnoses based on ICD-10 codes. However, there is no information on diagnoses not linked with a hospitalization.
The primary outcomes were known side effects of propranolol, …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Related Articles
Cited By...
- No citing articles found.